U.S. jury hits Bayer with $81 million in Roundup cancer trial

March 27, 2019

(Reuters) – A U.S. jury on Wednesday awarded $80.9 million to a man who claimed his use of Bayer AG’s glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.

The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma.

(Reporting by Alexandria Sage in San Francisco; editing by Bill Berkrot)

Comments (No)

Leave a Reply